Finally, partial knock-down of E2f1 led to a modest reduction of E2f target gene expression but failed to modify the proliferative capacity of TKO HCC cells, in line with previous reports (Supplementary Fig. 4d,e). The gene discussed is E2F1; the disease is hepatocellular carcinoma.